Breast Care Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health System's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality. The data presented below is included in the CoC's quality of care measures for breast cancer, and are for 2010, the most recent year for which data is available. (Data provided by the National Cancer Database.)  

The purpose of the data is to compare the care of breast cancer patients at UC San Diego Health System with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below meaures. For more information about quality and safety measures, see Quality Care.

Combination chemotherapy considered within four months of diagnosis (when appropriate) - diagnosis year 2010

UC San Diego Health System 100%
State of California 87.8%
Pacific Region 90.2%
Teaching Hospitals 90.5%
All Commission on Cancer Approved Programs 92.0%

Administration of hormone therapy considered within one year of diagnosis (when appropriate) - diagnosis year 2010

UC San Diego Health System 100%
State of California 82.2%
Pacific Region 84.8%
Teaching Hospitals 88.5%
All Commission on Cancer Approved Programs 88.4%